CR20150423A - Proceso de fabricación de vortioxetina - Google Patents

Proceso de fabricación de vortioxetina

Info

Publication number
CR20150423A
CR20150423A CR20150423A CR20150423A CR20150423A CR 20150423 A CR20150423 A CR 20150423A CR 20150423 A CR20150423 A CR 20150423A CR 20150423 A CR20150423 A CR 20150423A CR 20150423 A CR20150423 A CR 20150423A
Authority
CR
Costa Rica
Prior art keywords
vortioxetin
manufacturing process
dimethylthiophenol
decomplexation
vortioxetine
Prior art date
Application number
CR20150423A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CR20150423A publication Critical patent/CR20150423A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
CR20150423A 2013-02-22 2015-08-18 Proceso de fabricación de vortioxetina CR20150423A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22
PCT/EP2014/053313 WO2014128207A1 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Publications (1)

Publication Number Publication Date
CR20150423A true CR20150423A (es) 2015-10-20

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150423A CR20150423A (es) 2013-02-22 2015-08-18 Proceso de fabricación de vortioxetina

Country Status (37)

Country Link
US (1) US9353073B2 (enExample)
EP (1) EP2958903B1 (enExample)
JP (1) JP6464098B2 (enExample)
KR (1) KR102230628B1 (enExample)
CN (1) CN104995181B (enExample)
AP (1) AP2015008640A0 (enExample)
AU (1) AU2014220735B2 (enExample)
BR (1) BR112015019268B1 (enExample)
CA (1) CA2901821A1 (enExample)
CL (1) CL2015002309A1 (enExample)
CR (1) CR20150423A (enExample)
CY (1) CY1118883T1 (enExample)
DK (1) DK2958903T3 (enExample)
DO (1) DOP2015000187A (enExample)
EA (1) EA027756B1 (enExample)
ES (1) ES2625380T3 (enExample)
GE (1) GEP201706749B (enExample)
HR (1) HRP20170607T1 (enExample)
IL (1) IL240501B (enExample)
LT (1) LT2958903T (enExample)
MA (1) MA38338B1 (enExample)
ME (1) ME02671B (enExample)
MX (1) MX362355B (enExample)
MY (1) MY172337A (enExample)
PE (1) PE20151589A1 (enExample)
PH (1) PH12015501807B1 (enExample)
PL (1) PL2958903T3 (enExample)
PT (1) PT2958903T (enExample)
RS (1) RS55932B1 (enExample)
RU (1) RU2652265C2 (enExample)
SG (1) SG11201506651SA (enExample)
SI (1) SI2958903T1 (enExample)
SM (1) SMT201700238T1 (enExample)
TN (1) TN2015000335A1 (enExample)
UA (1) UA116236C2 (enExample)
WO (1) WO2014128207A1 (enExample)
ZA (1) ZA201506050B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2605652T3 (pl) 2010-08-18 2018-04-30 Samumed, Llc Diketony i hydroksyketony jako aktywatory szlaku sygnalizacji kateninowej
PE20151721A1 (es) 2013-02-22 2015-12-07 Samumed Llc Y-dicetonas como activadores de la ruta de senalizacion de wnt/b-catenina
KR102165385B1 (ko) 2014-08-20 2020-10-15 사뮤메드, 엘엘씨 피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
CN109071374A (zh) * 2016-02-08 2018-12-21 Aaa化学公司 脂肪胺的芳基化
BR112018003930A2 (pt) 2016-07-01 2018-09-25 H Lundbeck As regimes de dosagem de vortioxetina para início rápido de efeito antidepressivo
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
CN100457738C (zh) * 2001-12-20 2009-02-04 H·隆德贝克有限公司 芳氧基苯基和芳硫基苯基衍生物
EP2439201B1 (en) * 2006-06-16 2013-08-07 H. Lundbeck A/S Compounds with combined sert, 5-ht3 and 5-ht1a activity
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
MX362355B (es) 2019-01-14
SG11201506651SA (en) 2015-09-29
CY1118883T1 (el) 2018-01-10
JP2016509042A (ja) 2016-03-24
BR112015019268A2 (pt) 2020-01-28
DK2958903T3 (en) 2017-05-15
EP2958903B1 (en) 2017-04-12
CA2901821A1 (en) 2014-08-28
TN2015000335A1 (en) 2017-01-03
ME02671B (me) 2017-06-20
US9353073B2 (en) 2016-05-31
SI2958903T1 (sl) 2017-09-29
GEP201706749B (en) 2017-10-10
WO2014128207A1 (en) 2014-08-28
JP6464098B2 (ja) 2019-02-06
HK1216098A1 (en) 2016-10-14
PH12015501807A1 (en) 2015-11-09
UA116236C2 (uk) 2018-02-26
PL2958903T3 (pl) 2017-08-31
MY172337A (en) 2019-11-21
RS55932B1 (sr) 2017-09-29
KR102230628B1 (ko) 2021-03-22
MA38338A1 (fr) 2016-09-30
US20160009670A1 (en) 2016-01-14
CN104995181A (zh) 2015-10-21
PT2958903T (pt) 2017-05-26
EA201591349A1 (ru) 2015-12-30
AP2015008640A0 (en) 2015-08-31
PE20151589A1 (es) 2015-12-03
CL2015002309A1 (es) 2016-03-04
AU2014220735B2 (en) 2017-06-22
MA38338B1 (fr) 2018-10-31
RU2015134407A (ru) 2017-03-28
LT2958903T (lt) 2017-08-25
MX2015010656A (es) 2015-12-17
EA027756B1 (ru) 2017-08-31
ZA201506050B (en) 2017-08-30
KR20150118146A (ko) 2015-10-21
RU2652265C2 (ru) 2018-04-27
EP2958903A1 (en) 2015-12-30
BR112015019268B1 (pt) 2023-01-10
DOP2015000187A (es) 2015-11-30
SMT201700238T1 (it) 2017-07-18
CN104995181B (zh) 2017-03-08
ES2625380T3 (es) 2017-07-19
AU2014220735A1 (en) 2015-08-20
HRP20170607T1 (hr) 2017-06-30
IL240501A0 (en) 2015-09-24
PH12015501807B1 (en) 2019-05-31
IL240501B (en) 2018-08-30

Similar Documents

Publication Publication Date Title
CR20150423A (es) Proceso de fabricación de vortioxetina
MX2015016535A (es) Metodo de produccion para tagatosa.
AR095048A1 (es) Proceso electroquímico para el acoplamiento de fenol a anilina
MX2015015906A (es) Mejoras en o con relacion a compuestos organicos.
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
CU20160003A7 (es) Pirazololpiridinaminas sustituidas
MX2016000390A (es) Proceso para fabricar haloacetamidas.
MX2015015151A (es) Metodo para producir 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos, donde dicho proceso usa reciclado.
MX2016006977A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles.
IL282224A (en) Novel carbon nano-structures for energy generation applications
AR098592A1 (es) Formas cristalinas de 1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azulenos
MX2020009462A (es) Procesos para la preparación de compuestos de pirimidinilciclopentano.
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
GT201500225A (es) Proceso para producir compuesto de piridazinona y producciond e sus intermediarios
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
ECSP15036884A (es) Proceso de fabricación de vortioxetina
CR20150484A (es) Método de producción de compuestos de piridazinona
BR112015028751A2 (pt) processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
BR112016008697B8 (pt) Método para produzir halocetonas
BR112015017326A2 (pt) processo para a produção de 2-alquil-3-butin-2-óis
MX2013005287A (es) Proceso para fabricar un articulo que comprende un rebaje y articulo.
UA87254U (ru) Соединение 1,1-диэтилкарбокси-2-метокси-2-трифторметилэтилен с потенциальными физиологическими свойствами
UA89447U (ru) Соединение 1,1-диэтилкарбокси-2-хлор-2-трифторметилэтилен с потенциальными физиологическими свойствами